MT-1 (Melanotanl)

Increased Skin Pigmentation / Sunless Tanning: Research on Melanotan-1 (MT-1) has shown it enhances skin pigmentation by stimulating melanin production, leading to a tanning effect. Clinical trials demonstrated that MT-1, combined with UV-B light or sunlight, significantly increased tanning while reducing sunburn cells (1).

Studies demonstrated that higher doses produced more pronounced and longer-lasting pigmentation compared to sunlight alone. Side effects were minor, including nausea and facial flushing. While MT-1 shows promise for safe tanning, concerns about unregulated products and long-term health effects warrant further investigation (2).

Photoprotection and Sun-Sensitivity Treatment: Research has demonstrated that Melanotan-1 provides photoprotection and treats sun sensitivity by stimulating eumelanin production through melanocortin-1 receptor activation. It is particularly effective for erythropoietic protoporphyria (EPP), a condition causing severe phototoxicity (3).

Clinical studies show afamelanotide significantly increases sunlight tolerance, reduces pain from light exposure, and improves quality of life for EPP patients. Administered subcutaneously, it enhances pain-free time in sunlight and is well-tolerated, with minor side effects like headache and nausea (4).

Promising Therapies for Skin Conditions: Research suggests that Melanotan-1 shows promise as a therapy for skin conditions like vitiligo by stimulating melanogenesis and promoting repigmentation. Vitiligo, characterized by the loss of melanocytes and resulting white macules, lacks a definitive cure.

Melanotan-1’s ability to activate melanocortin-1 receptors and enhance eumelanin production offers a regenerative approach to restore pigmentation. While further research is needed, its potential to stabilize depigmentation and induce durable repigmentation makes it a promising option for vitiligo management (5).